Systemic Anti-Cancer Therapy governance framework and audit tool

Systemic Anti-Cancer Therapy (SACT) encompasses both biological therapy (therapies which use the body's immune system to fight cancer or to lessen the side effects that may be caused by some cancer treatments) and cytotoxic chemotherapy (a group of medicines containing chemicals directly toxic to cells preventing their replication or growth, and so active against cancer).

CEL 30 (2012) ‘[Revised] Guidance for the Safe Delivery of Systemic Anti-Cancer Therapy’, published by the Scottish Government in July 2012 provides guidance on the safe delivery of SACT.

The Systemic Anti Cancer Therapy working group, convened by Healthcare Improvement Scotland in September 2012, developed the Systemic Anti-Cancer Therapy governance framework and audit tool to support the implementation of this guidance.

NHS boards will use the audit tool to self-assess SACT services by September 2013, following which a three-year rolling programme of peer review will be implemented, with results reported to the Scottish Cancer Taskforce through an expert review group.

This work forms part of the Medicines Strategy, and is linked to the Cancer Quality Performance Indicators (QPIs) programme.

Published Date: 10 April 2013